Ayala Pharmaceuticals (ADXS) Stock Chart & Stock Price History $0.12 +0.09 (+280.70%) As of 06/13/2025 11:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Ayala Pharmaceuticals Stock Price Performance The Ayala Pharmaceuticals (ADXS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 53.91%, with a year-to-date return of 345.56%. In the past month, the stock has increased 301.00%, reflecting recent market activity. As of the latest close, Ayala Pharmaceuticals traded at $0.12 with a market cap of $5.13 million and volume of 1,730 shares. Receive ADXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+259.10%1 Month Performance+301.00%3 Month Performance+301.00%Year-To-Date Performance+345.56%1 Year Performance-53.91% ADXS Stock Chart for Saturday, June, 14, 2025 ADXS Chart by TradingView Ayala Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.03$0.12+280.70%$0.12$0.041,730 shs$5.13 million06/12/2025$0.03$0.03-5.67%$0.03$0.03993 shs$1.35 million06/10/2025$0.03$0.03$0.03$0.03735 shs$1.43 million06/09/2025$0.03$0.03+1.21%$0.03$0.03735 shs$1.43 million06/06/2025$0.03$0.03-1.19%$0.03$0.03484 shs$1.41 million06/05/2025$0.03$0.03+0.60%$0.03$0.032,012 shs$1.43 million06/04/2025$0.03$0.03+2.46%$0.34$0.03911 shs$1.42 million06/03/2025$0.03$0.03-2.40%$0.03$0.03434 shs$1.39 million06/02/2025$0.03$0.03-2.63%$0.03$0.031,026 shs$1.42 million05/30/2025$0.03$0.03-2.01%$0.03$0.03233 shs$1.46 million Get the Latest News and Ratings for ADXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$0.03$0.03$0.03$0.0330 shs$1.49 million05/28/2025$0.03$0.03$0.03$0.0379 shs$1.49 million05/27/2025$0.03$0.03$0.03$0.03284 shs$1.49 million05/26/2025$0.03$0.03$0.03$0.03284 shs$1.49 million05/23/2025$0.04$0.03-6.93%$0.03$0.03284 shs$1.49 million05/22/2025$0.04$0.04$0.04$0.04176 shs$1.60 million05/21/2025$0.04$0.04$0.04$0.04205 shs$1.60 million05/20/2025$0.04$0.04$0.04$0.04205 shs$1.60 million05/19/2025$0.03$0.04+9.65%$0.04$0.04205 shs$1.60 million05/16/2025$0.03$0.03+14.00%$0.03$0.033,279 shs$1.46 million05/15/2025$0.03$0.03$0.03$0.03325 shs$1.28 million05/14/2025$0.04$0.03-25.19%$0.03$0.032,772 shs$1.28 million05/13/2025$0.04$0.04$0.04$0.0443 shs$1.71 million Related Companies Biofrontera Stock Price Chart Mustang Bio Stock Price Chart Ensysce Biosciences Stock Price Chart CNS Pharmaceuticals Stock Price Chart Fresh Tracks Therapeutics Stock Price Chart Indaptus Therapeutics Stock Price Chart Sonoma Pharmaceuticals Stock Price Chart Kazia Therapeutics Stock Price Chart China Pharma Stock Price Chart Cyclacel Pharmaceuticals Stock Price Chart Receive ADXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADXS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ayala Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
